{
    "@context": {
        "schema": "https://schema.org/",
        "dct": "http://purl.org/dc/terms/",
        "hg": "https://hormuz.group/data/ns#"
    },
    "id": "hg:company:alhavi-pharmaceutical-company",
    "identifier": "hg:company:alhavi-pharmaceutical-company",
    "dataset_type": "entity_dataset",
    "entity_type": "company",
    "data_version": "2.0",
    "generated_by": "Hormuz Data Layer 0.2.1",
    "generated_at": "2026-07-04T02:51:17+00:00",
    "name": "Alhavi Pharmaceutical Company",
    "slug": "alhavi-pharmaceutical-company",
    "status": "publish",
    "url": "https://hormuz.group/companies/alhavi-pharmaceutical-company/",
    "json_url": "https://hormuz.group/wp-content/uploads/hormuz-data/cpt/company/alhavi-pharmaceutical-company.json",
    "rest_url": "https://hormuz.group/wp-json/hormuz-data/v1/cpt/company/alhavi-pharmaceutical-company",
    "summary": "",
    "machine_summary": "Alhavi Pharmaceutical Company Alhavi Pharmaceutical Company is a Tehran-based pharmaceutical manufacturer with roots in the former Parke-Davis facility on the Tehran-Karaj corridor. In the Hormuz Group company graph, it matters because it connects local medicine manufacturing, pediatric products, oral dosage forms, healthcare distribution, and pharmaceutical quality systems. Its role is most relevant to domestic drug availability and import substitution rather than direct capital-market exposure. Alhavi is relevant for investors assessing Iran's private pharmaceutical manufacturing base, domestic drug supply resilience, pediatric medicine demand, quality-system maturity, and dependence on imported active ingredients and excipients. It can support analysis of medicine shortages, pharmacy-channel supply, contract manufacturing potential, and regulated healthcare demand. Due diligence should verify ownership, current licenses, GMP status, product registrations, raw-material sourcing, distributor relationships, factory utilization, export activity, and exposure to pricing regulation. Alhavi Pharmaceutical Company manufactures pharmaceutical products in dosage forms including tablets, capsules, syrups, elixirs, suspensions, drops, and pediatric medicines. Its operations are linked to domestic drug supply, pharmacy distribution, child-health products, common therapeutic categories, imported pharmaceutical inputs, quality systems, and regulated healthcare manufacturing. province: Tehran industry: Healthcare & Pharma, Manufacturing, Pharmaceuticals market: Consumer Demand, Healthcare, Materials, Supply Chains challenges: Compliance, Import Dependence, Supply Shortage, Technology Gap company_type: Manufacturer city: Tehran",
    "published_at": "2026-06-28T20:21:36+00:00",
    "modified_at": "2026-06-28T20:21:36+00:00",
    "taxonomies": {
        "province": [
            {
                "id": 3,
                "name": "Tehran",
                "slug": "tehran",
                "url": "https://hormuz.group/provinces/tehran/"
            }
        ],
        "industry": [
            {
                "id": 21,
                "name": "Healthcare & Pharma",
                "slug": "healthcare-pharma",
                "url": "https://hormuz.group/industry/healthcare-pharma/"
            },
            {
                "id": 16,
                "name": "Manufacturing",
                "slug": "manufacturing",
                "url": "https://hormuz.group/industry/manufacturing/"
            },
            {
                "id": 121,
                "name": "Pharmaceuticals",
                "slug": "pharmaceuticals",
                "url": "https://hormuz.group/industry/healthcare-pharma/pharmaceuticals/"
            }
        ],
        "market": [
            {
                "id": 34,
                "name": "Consumer Demand",
                "slug": "consumer-demand",
                "url": "https://hormuz.group/market/consumer-demand/"
            },
            {
                "id": 69,
                "name": "Healthcare",
                "slug": "healthcare",
                "url": "https://hormuz.group/market/consumer-demand/healthcare/"
            },
            {
                "id": 73,
                "name": "Materials",
                "slug": "materials",
                "url": "https://hormuz.group/market/enterprise-demand/materials/"
            },
            {
                "id": 76,
                "name": "Supply Chains",
                "slug": "supply-chains",
                "url": "https://hormuz.group/market/enterprise-demand/supply-chains/"
            }
        ],
        "challenges": [
            {
                "id": 164,
                "name": "Compliance",
                "slug": "compliance",
                "url": "https://hormuz.group/challenges/regulatory-barriers/compliance/"
            },
            {
                "id": 176,
                "name": "Import Dependence",
                "slug": "import-dependence",
                "url": "https://hormuz.group/challenges/market-gaps/import-dependence/"
            },
            {
                "id": 177,
                "name": "Supply Shortage",
                "slug": "supply-shortage",
                "url": "https://hormuz.group/challenges/market-gaps/supply-shortage/"
            },
            {
                "id": 179,
                "name": "Technology Gap",
                "slug": "technology-gap",
                "url": "https://hormuz.group/challenges/market-gaps/technology-gap/"
            }
        ],
        "company_type": [
            {
                "id": 299,
                "name": "Manufacturer",
                "slug": "manufacturer",
                "url": "https://hormuz.group/company-type/manufacturer/"
            }
        ],
        "city": [
            {
                "id": 384,
                "name": "Tehran",
                "slug": "tehran",
                "url": "https://hormuz.group/cities/tehran/"
            }
        ]
    },
    "taxonomy_labels": {
        "province": "Tehran",
        "industry": "Healthcare & Pharma, Manufacturing, Pharmaceuticals",
        "market": "Consumer Demand, Healthcare, Materials, Supply Chains",
        "challenges": "Compliance, Import Dependence, Supply Shortage, Technology Gap",
        "company_type": "Manufacturer",
        "city": "Tehran"
    },
    "fields_summary": {
        "legal_name": "Alhavi Pharmaceutical Company",
        "website": "https://www.alhavipharma.com",
        "city": "Tehran, Tehran Province, Iran",
        "ticker_symbol": "",
        "listing_status": "private",
        "products_services": "Alhavi Pharmaceutical Company manufactures pharmaceutical products in dosage forms including tablets, capsules, syrups, elixirs, suspensions, drops, and pediatric medicines. Its operations are linked to domestic drug supply, pharmacy distribution, child-health products, common therapeutic categories, imported pharmaceutical inputs, quality systems, and regulated healthcare manufacturing.",
        "export_relevance": "low",
        "short_profile": "Alhavi Pharmaceutical Company is a Tehran-based pharmaceutical manufacturer with roots in the former Parke-Davis facility on the Tehran-Karaj corridor. In the Hormuz Group company graph, it matters because it connects local medicine manufacturing, pediatric products, oral dosage forms, healthcare distribution, and pharmaceutical quality systems. Its role is most relevant to domestic drug availability and import substitution rather than direct capital-market exposure.",
        "investment_relevance": "Alhavi is relevant for investors assessing Iran's private pharmaceutical manufacturing base, domestic drug supply resilience, pediatric medicine demand, quality-system maturity, and dependence on imported active ingredients and excipients. It can support analysis of medicine shortages, pharmacy-channel supply, contract manufacturing potential, and regulated healthcare demand. Due diligence should verify ownership, current licenses, GMP status, product registrations, raw-material sourcing, distributor relationships, factory utilization, export activity, and exposure to pricing regulation."
    },
    "fields": {
        "rank_math_internal_links_processed": "1",
        "wp_statistics_words_count": "0",
        "legal_name": "Alhavi Pharmaceutical Company",
        "city": "Tehran, Tehran Province, Iran",
        "ticker_symbol": "",
        "export_relevance": "low",
        "verification_status": "basic",
        "data_confidence": "high",
        "listing_status": "private",
        "last_updated": "28/06/2026",
        "website": "https://www.alhavipharma.com",
        "products_services": "Alhavi Pharmaceutical Company manufactures pharmaceutical products in dosage forms including tablets, capsules, syrups, elixirs, suspensions, drops, and pediatric medicines. Its operations are linked to domestic drug supply, pharmacy distribution, child-health products, common therapeutic categories, imported pharmaceutical inputs, quality systems, and regulated healthcare manufacturing.",
        "short_profile": "Alhavi Pharmaceutical Company is a Tehran-based pharmaceutical manufacturer with roots in the former Parke-Davis facility on the Tehran-Karaj corridor. In the Hormuz Group company graph, it matters because it connects local medicine manufacturing, pediatric products, oral dosage forms, healthcare distribution, and pharmaceutical quality systems. Its role is most relevant to domestic drug availability and import substitution rather than direct capital-market exposure.",
        "investment_relevance": "Alhavi is relevant for investors assessing Iran's private pharmaceutical manufacturing base, domestic drug supply resilience, pediatric medicine demand, quality-system maturity, and dependence on imported active ingredients and excipients. It can support analysis of medicine shortages, pharmacy-channel supply, contract manufacturing potential, and regulated healthcare demand. Due diligence should verify ownership, current licenses, GMP status, product registrations, raw-material sourcing, distributor relationships, factory utilization, export activity, and exposure to pricing regulation.",
        "source_note": "Based on public company, official-company, pharmaceutical-sector, healthcare, and market-related information. Further verification is required before treating this profile as verified investment intelligence."
    },
    "field_profile": {
        "rank_math_internal_links_processed": {
            "type": "string",
            "present": true,
            "length": 1
        },
        "wp_statistics_words_count": {
            "type": "string",
            "present": true,
            "length": 1
        },
        "legal_name": {
            "type": "string",
            "present": true,
            "length": 29
        },
        "city": {
            "type": "string",
            "present": true,
            "length": 29
        },
        "ticker_symbol": {
            "type": "string",
            "present": false,
            "length": 0
        },
        "export_relevance": {
            "type": "string",
            "present": true,
            "length": 3
        },
        "verification_status": {
            "type": "string",
            "present": true,
            "length": 5
        },
        "data_confidence": {
            "type": "string",
            "present": true,
            "length": 4
        },
        "listing_status": {
            "type": "string",
            "present": true,
            "length": 7
        },
        "last_updated": {
            "type": "string",
            "present": true,
            "length": 10
        },
        "website": {
            "type": "string",
            "present": true,
            "length": 28
        },
        "products_services": {
            "type": "string",
            "present": true,
            "length": 390
        },
        "short_profile": {
            "type": "string",
            "present": true,
            "length": 471
        },
        "investment_relevance": {
            "type": "string",
            "present": true,
            "length": 594
        },
        "source_note": {
            "type": "string",
            "present": true,
            "length": 208
        }
    },
    "sources": [
        {
            "type": "note",
            "value": "Based on public company, official-company, pharmaceutical-sector, healthcare, and market-related information. Further verification is required before treating this profile as verified investment intelligence."
        }
    ],
    "quality": {
        "required_fields": [
            "legal_name",
            "website",
            "city",
            "listing_status",
            "products_services",
            "export_relevance",
            "verification_status",
            "data_confidence",
            "short_profile",
            "investment_relevance",
            "source_note",
            "last_updated"
        ],
        "missing_required_fields": [],
        "missing_required_count": 0,
        "verification_status": "basic",
        "data_confidence": "high",
        "last_updated": "28/06/2026",
        "stale_over_180_days": false,
        "quality_score": 100
    },
    "verification": {
        "verification_status": "basic",
        "data_confidence": "high",
        "last_updated": "28/06/2026"
    }
}